[How and why does the metabolic equilibrium of the mother affect the embryo?].
Prevalence of congenital malformations in infants born to women with diabetes mellitus remains high (between 6 and 10%), which is between 3 and 5 times higher than in the general population. Major congenital anomalies are 7 to 10 times more frequent in infants born to diabetics. Normal pregnancy is a state of metabolic stress that requires a high degree of maternal physiological adaptation to help optimize fetal growth. Decreased insulin sensitivity throughout pregnancy with reactional hyperinsulinism helps metabolic efficiency. Changes are observed in glucose, lipid and protein metabolism during pregnancy with a rapid switch from anabolism to catabolism. Diabetic women have absolute or relative insulin deficiency and display abnormalities in carbohydrate, lipid and protein metabolism. These abnormalities can adversely affect embryo growth and explain the high prevalence of spontaneous abortions and congenital malformations. There is a multifactorial origin, of which hyperglycemia in early embryo development is the most important. Hyperglycemia-induced malformations are mediated by sorbital accumulation, arachidonic acid and myoinositol deficiencies and high concentrations of beta-hydroxybutyrate. Accumulation of free oxygen radicals by increased formation and decreased clearance may serve as metabolic common denominators for teratogenic processes. Other factors such as zinc deficiency, the presence of somatomedin inhibitors and released TNF alpha are candidates. Human clinical studies are not consistent with a genetic predisposition to diabetes-related malformations. Progress is needed in pre-conception care of diabetes and blood glucose must be strictly controlled during early pregnancy.
Fontaine
P
P
C.H.R.U. Clinique Marc Linquette, Service d'Endocrino-Diabétologie, Rue du Professeur Laguesse, 59037 Lille. p-fontaine@chru-lille.fr
D000013:Congenital Abnormalities / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000503:physiopathology*; D005314:Embryonic and Fetal Development; D005260:Female; D006706:Homeostasis; D006801:Humans; D006946:Hyperinsulinism / Q000503:physiopathology; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology*; D012016:Reference Values
Comment et pourquoi l'équilibre métabolique de la mère affecte-t-il l'embryon?